PTC Therapeutics, Inc.

PTCTNASDAQHealthcare● Active

$70.70

$-0.28(-0.39%)

Market Cap$5.9B

P/E Ratio—

52W High$87.5

52W Low$43.175

Avg Volume1.2M

Open$70.96

Beta0.55

Insider Trades Ownership Employees

PTC Therapeutics, Inc.（PTCT）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · PTCT · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

182

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

PTC Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

PTCT 季度内部人买卖趋势

PTCT 内幕交易卖出 · PTCT 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

869K434K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · PTCT CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

PTCT 高管卖出股份 · PTCT 董事内幕交易 · SEC Form 4申报

显示最近 88 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 15, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Option	2,812	$25.69	$72K	108,024	Form 4
May 15, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Sale	2,356	$72.08	$170K	105,668	Form 4
May 15, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Sale	456	$72.67	$33K	105,212	Form 4
May 13, 2026	Klein Matthew B. CHIEF EXECUTIVE OFFICER · Director	Award	12,500	—	—	406,570	Form 4
May 14, 2026	Klein Matthew B. CHIEF EXECUTIVE OFFICER · Director	Sale	679	$73.06	$50K	405,891	Form 4
May 14, 2026	Klein Matthew B. CHIEF EXECUTIVE OFFICER · Director	Sale	7,221	$73.08	$528K	398,670	Form 4
May 14, 2026	Klein Matthew B. CHIEF EXECUTIVE OFFICER · Director	Sale	2,100	$73.08	$153K	396,570	Form 4
May 14, 2026	Klein Matthew B. CHIEF EXECUTIVE OFFICER · Director	Sale	2,572	$72.46	$186K	393,998	Form 4
May 8, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Option	2,740	$46.54	$128K	107,952	Form 4
May 8, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Sale	840	$78.23	$66K	107,112	Form 4
May 8, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Option	800	$46.54	$37K	106,012	Form 4
May 8, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Sale	200	$78.00	$16K	105,812	Form 4
May 8, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Sale	1,900	$79.31	$151K	105,212	Form 4
May 8, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Sale	600	$79.28	$48K	105,212	Form 4
Apr 21, 2026	Klein Matthew B. CHIEF EXECUTIVE OFFICER · Director	Sale	2,850	$70.91	$202K	394,070	Form 4
Apr 6, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Option	2,265	$39.42	$89K	107,477	Form 4
Apr 6, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Sale	822	$68.91	$57K	106,655	Form 4
Apr 6, 2026	Boulding Mark Elliott EXEC. VP AND CLO	Sale	1,443	$69.75	$101K	105,212	Form 4
Apr 2, 2026	Golden Lee Scott EVP & CHIEF MEDICAL OFFICER	Sale	829	$67.99	$56K	79,115	Form 4
Apr 1, 2026	Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER	Sale	39,393	$68.89	$2.71M⚡	72,747	Form 4
Apr 1, 2026	Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER	Sale	12,530	$69.50	$871K	60,217	Form 4
Apr 1, 2026	Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER	Sale	80	$70.30	$6K	60,137	Form 4
Mar 24, 2026	Chutter Jessica Caroline Director	Award	3,333	—	—	7,333	Form 4
Mar 24, 2026	Chutter Jessica Caroline Director	Award	4,000	—	—	4,000	Form 4
Mar 11, 2026	Klein Matthew B. CHIEF EXECUTIVE OFFICER · Director	Award	12,500	—	—	399,582	Form 4

Boulding Mark Elliott

EXEC. VP AND CLO

Option

日期

May 15

股数

2,812

均价

$25.69

总金额

$72K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Sale

日期

May 15

股数

2,356

均价

$72.08

总金额

$170K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Sale

日期

May 15

股数

456

均价

$72.67

总金额

$33K

View Form 4 on SEC.gov

Klein Matthew B.

CHIEF EXECUTIVE OFFICER · Director

Award

日期

May 13

股数

12,500

均价

—

总金额

—

View Form 4 on SEC.gov

Klein Matthew B.

CHIEF EXECUTIVE OFFICER · Director

Sale

日期

May 14

股数

679

均价

$73.06

总金额

$50K

View Form 4 on SEC.gov

Klein Matthew B.

CHIEF EXECUTIVE OFFICER · Director

Sale

日期

May 14

股数

7,221

均价

$73.08

总金额

$528K

View Form 4 on SEC.gov

Klein Matthew B.

CHIEF EXECUTIVE OFFICER · Director

Sale

日期

May 14

股数

2,100

均价

$73.08

总金额

$153K

View Form 4 on SEC.gov

Klein Matthew B.

CHIEF EXECUTIVE OFFICER · Director

Sale

日期

May 14

股数

2,572

均价

$72.46

总金额

$186K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Option

日期

May 8

股数

2,740

均价

$46.54

总金额

$128K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Sale

日期

May 8

股数

840

均价

$78.23

总金额

$66K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Option

日期

May 8

股数

800

均价

$46.54

总金额

$37K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Sale

日期

May 8

股数

200

均价

$78.00

总金额

$16K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Sale

日期

May 8

股数

1,900

均价

$79.31

总金额

$151K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Sale

日期

May 8

股数

600

均价

$79.28

总金额

$48K

View Form 4 on SEC.gov

Klein Matthew B.

CHIEF EXECUTIVE OFFICER · Director

Sale

日期

Apr 21

股数

2,850

均价

$70.91

总金额

$202K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Option

日期

Apr 6

股数

2,265

均价

$39.42

总金额

$89K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Sale

日期

Apr 6

股数

822

均价

$68.91

总金额

$57K

View Form 4 on SEC.gov

Boulding Mark Elliott

EXEC. VP AND CLO

Sale

日期

Apr 6

股数

1,443

均价

$69.75

总金额

$101K

View Form 4 on SEC.gov

Golden Lee Scott

EVP & CHIEF MEDICAL OFFICER

Sale

日期

Apr 2

股数

829

均价

$67.99

总金额

$56K

View Form 4 on SEC.gov

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Sale

日期

Apr 1

股数

39,393

均价

$68.89

总金额

$2.71M ⚡

View Form 4 on SEC.gov

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Sale

日期

Apr 1

股数

12,530

均价

$69.50

总金额

$871K

View Form 4 on SEC.gov

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Sale

日期

Apr 1

股数

均价

$70.30

总金额

$6K

View Form 4 on SEC.gov

Chutter Jessica Caroline

Director

Award

日期

Mar 24

股数

3,333

均价

—

总金额

—

View Form 4 on SEC.gov

Chutter Jessica Caroline

Director

Award

日期

Mar 24

股数

4,000

均价

—

总金额

—

View Form 4 on SEC.gov

Klein Matthew B.

CHIEF EXECUTIVE OFFICER · Director

Award

日期

Mar 11

股数

12,500

均价

—

总金额

—

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 4

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 PTCT 内幕交易

PTCT 内幕交易

PTC Therapeutics, Inc.（PTCT）内幕交易数据来源于公司内部人（包括Boulding Mark Elliott (EXEC. VP AND CLO), Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER), Klein Matthew B. (CHIEF EXECUTIVE OFFICER · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。PTCT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看PTC Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

PTCT 内幕交易 · 5个问题

PTC Therapeutics, Inc.（PTCT）的内部人包括高管和董事，如Boulding Mark Elliott (EXEC. VP AND CLO), Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER), Klein Matthew B. (CHIEF EXECUTIVE OFFICER · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

PTCT 董事内幕交易PTCT 内部人名单PTC Therapeutics, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026